ReviewCancers2021

Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis.

Francesco Schettini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.